VR2Market

About Project

VR2Market: Towards a Mobile Wearable Health Surveillance Product for First Response and other Hazardous Professions

The main goal of the VitalResponder® is to develop technologies to monitor the occupational health of first responders. The research line of the VitalResponder® is now being developed as part of a CMU Portugal project, called "VR2Market: Towards a Mobile Wearable Health Surveillance Monitoring Product for First Response and other Hazardous Professions". The research is being conducted in Portugal by a consortium that brings together several research centres, a medical device company with various end users, psychology consulting services, and Carnegie Mellon University, United States.

Acronym

VR2Market

Responsible

João Paulo Trigueiros da Silva Cunha

Status

Closed

Start

January 15, 2014

End

January 30, 2019

Effective End

January 30, 2019

Global Budget

€500,000.00

Financing

€412,000.00

Members

Team Leaders

João Paulo Cunha is Full Professor of Bioengineering & Electrical & Computers Engineering (ECE) at the Department of ECE of the Faculty of Engineering of the University of Porto (FEUP), Portugal; Senior Researcher at the INESC-TEC: Institute for Systems and Computer Engineering where he created and coordinates the BRAIN – Biomedical Research And INnovation - research group and co-founded the Center for Biomedical Engineering Research (C-BER) that aggregates ~40 researchers. Prof. Cunha is also a mentor/co-founder and contributor to several MedTech/DeepTech startups (eight until now) by advising and licensing intellectual property of innovative biomedical technology developed for several years in his lab, such as Biodevices (http://www.biodevices.pt), iLof-Intelligent Lab-on-Fiber (https://ilof.tech) and inSignals Neurotech (http://www.insignals-neurotech.com). He is visiting professor at the Neurology Dep., Faculty of Medicine of the University of Munich, Germany since 2002 and at the Carnegie Mellon University – Silicon Valley Campus, USA, between 2016 and 2021. He serves as Scientific Director of the Carnegie-Mellon | Portugal program since 2014.

He earned a degree in Electronics and Telecommunications engineering (1989), a Ph.D. (1996) and an Habilitation (“Agregação”) degree (2009) in Electrical Engineering all at the University of Aveiro, Portugal.

Dr. Cunha is Senior Member of the IEEE – Institute of Electrical & Electronics Engineers - (2004), member of the Editorial Board of NATURE/Scientific Reports (5th most cited journal in 2022) and Associate Editor of FRONTIERS/Signal Processing journal. He is also habitual reviewer of several IEEE journals and other relevant scientific journals such as PLoS ONE or Movement Disorders. He is an internationally renowned expert in advanced biosignal processing, human motion analysis and neuroimaging. He has supervised and co-supervised more than 15 PhD & Post-doc students in his areas of R&D. He received several awards, being the most relevant the European Epilepsy Academy (EUREPA) “Best Contribution for Clinical Epileptology” Award in 2002. Prof. Cunha is co-author of +200 scientific publications and 43 patents from 10 patent families, holding an h-index of 34 (Google Scholar), with +4,500 citations.

Team Members

Susana Cristina Marques Pais Rodrigues

João Paulo Trigueiros da Silva Cunha

Duarte Filipe Dias

Daniel Fernando Marques de Vasconcelos

Associated Centres

Biomedical Engineering Research

The impact that science and innovation can have on the prevention, early detection, and support for the diagnosis of various types of diseases is fully explored at our Centre for Biomedical Engineering Research (C-BER). Guided by an interdisciplinary approach that prioritises technology transfer with economic impact—through the creation of new systems, tools, and methods related to disease diagnosis and monitoring, ageing, human rehabilitation, physiotherapy, and functional assessment—our researchers are dedicated to developing advanced technologies positioned at the intersection of engineering, medicine and health, and general well-being. Promoting strategic partnerships with clinical partners, research institutes, and encouraging international cooperation is one of the centre’s key priorities. Its research is structured across three distinct areas: Biomedical Imaging, Bioinstrumentation, and Neuroengineering.

Innovation, Technology and Entrepreneurship

The mission of our Centre for Innovation, Technology and Entrepreneurship (CITE) is to carry out multidisciplinary activities at the intersection of technology, innovation, sustainability, and management, promoting the exploration, implementation, and adoption of responsible and sustainable socio-technical systems. We focus on the areas of Innovation Management, Technology Management, and Technology-Based Entrepreneurship, exploring theories, methods, models, and tools to support the innovation process. Through research and innovation activities—including consultancy and advanced training—we address environmental, social, and economic challenges, contributing to the exploration, implementation, and adoption of innovative solutions. We create impact through research and innovation outcomes, aligning our activities with the Sustainable Development Goals (SDGs). We place high value on collaboration with both national and international partners. We are a member of the Enterprise Europe Network (EEN), where our mission is to support Portuguese companies on their innovation journey by identifying and fostering international partnerships for business or innovation development, while also helping to find the most relevant funding sources. We support the implementation of innovation management systems, integrating technology management with new business models and value chains, and promoting sustainable and responsible practices. We also run open innovation and acceleration programmes, contributing to the development of startups and the strengthening of innovation ecosystems. We work across three core areas: innovation management and the front end of innovation (FEI), technology management and policy, and entrepreneurship and business model innovation.